source
- Cambrian’s experimental longevity drug shown to mimic exercise effectsCambrian Therapeutics reported early data on a new compound aimed at extending healthy lifespan by reproducing some benefits of physical activity. The preclinical studies described in the newslett…
- Industry eyes revenue potential of next‑generation peptide drugs beyond GLP‑1The article notes that just a few years ago analysts were busy estimating the market size for GLP‑1 based weight‑loss medicines. Today the conversation has shifted toward the commercial possibilit…